Mon.Jul 17, 2023

article thumbnail

2023 Private Company Board Survey Insights

Harvard Corporate Governance

Posted by Claudia H. Allen, Patrick A. Lee, and Ari Weinberg, KPMG LLP, on Monday, July 17, 2023 Editor's Note: Claudia H. Allen and Patrick A. Lee are Senior Advisors, and Ari Weinberg is a Director at KPMG’s Board Leadership Center. This post is based on their KPMG memorandum. Adding value to private company boards From board structure and agenda priorities to the role of independent directors, private company governance continues to evolve in response to an increasingly complex and chal

Equity 235
article thumbnail

Mastering OKRs: How Artificial Intelligence Can Help You Set and Achieve Better Objectives and Key Results

Rhythm Systems

Implementing Rhythm Systems Software using artificial intelligence (AI) can be a game-changer for organizations looking to track, rate, and manage their objectives and key results (OKRs).

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Law and Stock Market Development in the UK Over Time: An Uneasy Match

Harvard Corporate Governance

Posted by Brian R. Cheffins (University of Cambridge), on Monday, July 17, 2023 Editor's Note: Brian Cheffins is the S. J. Berwin Professor of Corporate Law at the University of Cambridge. This post is based on a recent paper , co-authored with Bobby Reddy , also of the University of Cambridge, and forthcoming in the Oxford Journal of Legal Studies.

article thumbnail

Acquiring the advantage in a fast-evolving industry

Mckinsey and Company

As Nigeria’s vast network of small and medium-size enterprises increasingly look to digitalize payments, merchant acquiring is offering increasingly attractive prospects to banks and fintechs alike.

Banking 85
article thumbnail

How to Leverage Intent Data for Better Outcomes

Speaker: Susan Spencer, Principal of Spencer Communications

Intent signal data can go a long way toward shortening sales cycles and closing more deals. The challenge is deciding which is the best type of intent data to help your company meet its sales and marketing goals. In this webinar, Susan Spencer, fractional CMO and principal of Spencer Communications, will unpack the differences between contact-level and company-level intent signals.

article thumbnail

U.S. CEO Compensation Advantage Grows vs. U.K. Peers

Harvard Corporate Governance

Posted by Subodh Mishra, Institutional Shareholder Services, Inc., on Monday, July 17, 2023 Editor's Note: This post is based on an article by Ramy Ibrahim, Associate Director, Product Manager, ESG, Data Analytics & Financial Solutions, Yan Xu, Senior Associate, EMEA ESG Advisory, and Stephan Stegmueller, Executive Director, Head of Advisory EMEA & APAC at ISS Corporate Solutions.

article thumbnail

What is a Third-Party Vendor? Ncontracts

N Contracts

A third-party vendor refers to any external organization that engages in business activities with your financial institution. This includes everyone from your core provider and loan origination software to your outside counsel and the company that prints account statements.

82

More Trending

article thumbnail

A Multitude of Reasons to Obtain an Updated Business Appraisal

BV Specialists

Determining if you need to engage with an independent professional business appraiser will commonly arise when you are looking to purchase or sell a business. However, the fact is there are several other reasons an objective third-party appraisal is a great idea, and quite possibly a requirement to move forward with a transaction or to aid in a situation where a dispute may arise.

article thumbnail

What is psychological safety?

Mckinsey and Company

Psychological safety is the absence of interpersonal fear. Feeling psychologically safe allows people to perform their best at home, school, and work.

80
article thumbnail

SEC v. Ripple: Everyone Loses

Reynolds Holding

On July 13, Judge Analisa Torres handed down a long-awaited decision in SEC v. Ripple. Crypto enthusiasts immediately began celebrating the opinion as holding that XRP, the Ripple token, was not a security. Others welcomed the finding that certain XRP sales violated the securities laws but lamented that other sales were exempted. However, careful review of the decision leads to the conclusion that neither side should welcome this decision, which misconstrues basic principles underlying our marke

Finance 98
article thumbnail

Commanders, Atty Accused Of Defaming Exec After Testimony

Law 360 M&A

A former Washington Commanders executive has filed a $7.5 million defamation suit against the NFL team and one of its attorneys at Holland & Knight LLP, who called him a "serial liar" and a perjurer after he testified to Congress last year during an investigation into accusations of financial and workplace improprieties.

75
article thumbnail

Statement of Cash Flows vs. Cash Flow Statement

Speaker: Wayne Spivak - President and Chief Financial Officer of SBA * Consulting LTD, Industry Writer, and Public Speaker

The old adages that "cash is king" and "you can’t spend profits" still hold true today. But however well-known these sayings might be, it requires a change in mindset to properly implement a cash flow management system that predicts your business's runaway as accurately as possible. Key to this new mindset is understanding the difference between the Statement of Cash Flows, a historical look at the source and uses of cash, and the Cash Flow Statement, which uses transaction history and forward-l

article thumbnail

Why Asian insurers are ideally positioned for embedded market gains

Mckinsey and Company

Supportive regulations, intensifying competition, digital-savvy consumers, and a coverage gap have created favorable conditions for Asian insurers to consider embedded-insurance opportunities.

article thumbnail

Gamers Ask Justices To Halt Microsoft's $69B Activision Buy

Law 360 M&A

Gamers suing to stop Microsoft's planned $68.7 billion purchase of Activision Blizzard have asked the U.S. Supreme Court to press pause on the tie-up while they appeal the rejection of their earlier bid to halt the transaction.

75
article thumbnail

Middle managers are the heart of your company

Mckinsey and Company

Stop thinking of middle management as a way station. Instead, make it a destination.

93
article thumbnail

FTC Seeks Pause Of $28B Amgen Deal Amid Challenge

Law 360 M&A

The Federal Trade Commission has asked an Illinois federal court to issue a preliminary injunction preventing Amgen and Horizon Therapeutics from closing their planned $27.8 billion merger before an administrative case challenging the deal concludes.

75
article thumbnail

Mastering Intent Data: Understanding its Importance & Best Practices

Speaker: Joe Apfelbaum, CEO of Ajax Union

In this webinar, Joe Apfelbaum, CEO of Ajax Union and business strategist, will take you through the ABCs of intent data. You'll learn how to effectively use it to drive business results, with practical tips on how to leverage both company and contact intent data to maximize your marketing efforts. Whether you're a seasoned marketer or just getting started, this webinar is a must-attend for anyone looking to stay ahead in the ever-evolving world of digital marketing.

article thumbnail

Privacy and inclusivity: Keys to nurturing citizen trust

Avanade

Scott Cass-Dunbar shares the critical success factors for government organisations to foster trust and engage citizens.

69
article thumbnail

Microsoft, Sony Cut Call Of Duty Deal After FTC Court Loss

Law 360 M&A

Microsoft's Xbox chief announced Sunday that the company has reached a deal with rival Sony to keep Activision Blizzard's hit Call of Duty first-person shooter game on Sony's PlayStation following Microsoft's expected $68.7 billion acquisition of the game-maker and the U.S. Federal Trade Commission's recent trial court loss challenging the tie-up.

73
article thumbnail

MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022

Benzinga

MoonLake Immunotherapeutics (NASDAQ: MLTX ) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for inflammatory skin conditions. The is in preliminary talks with pharmaceutical companies interested in a potential acquisition. Citing the sources, Reuters emphasized that a deal isn't guaranteed and wished to remain anonymous.

Banking 52
article thumbnail

Tax Planning for Auto Dealerships

Auto Dealer Valuation Insights

In business valuation, appraisers seek to normalize historical earnings to establish the level of earnings an investor might reasonably expect from an investment in the subject company. These adjustments may increase or decrease earnings, and they can be set for a variety of reasons. Normalization adjustments include surveying various expense categories and determining whether the amount.

article thumbnail

Corsair Gaming Acquires Drop Assets, Bolstering Peripherals Business

Benzinga

Corsair Gaming Inc (NASDAQ: CRSR ) inked a deal to acquire certain assets from Drop in an all-cash transaction for an undisclosed amount. Drop develops and sells a portfolio of peripherals and enthusiast products, specializing in customized DIY keyboards, aftermarket designer keycaps, and. Full story available on Benzinga.

Equity 52
article thumbnail

A Student of Business

Exit Strategy

Those of you who know me well know that I like to call myself a “student of business.” Whenever I walk into a store or interact with a commercial business, I seem to default to a basic list of due diligence questions in my head: What is the cost structure for goods and expenses? How […] The post A Student of Business appeared first on Exit Strategies Group, Inc.

article thumbnail

Why Pardes Biosciences Shares Are Rising Monday

Benzinga

Pardes Biosciences Inc (NASDAQ: PRDS ) shares are trading higher Monday after MediPacific agreed to acquire the company. What Happened: Pardes entered into a definitive merger agreement in which MediPacific will acquire the company for $2.02 to $2.19 per share in cash, as well as contingent value rights associated with any future. Full story available on Benzinga.

52
article thumbnail

Delaware Court of Chancery Clarifies Heightened Standard for Recovery of Attorneys’ Fees in Disclosure-Based Deal Litigation

Shephard Mullin M&A

In Anderson v. Magellan Health, Inc. , No. 2021-0202, — A.3d —-, 2023 WL 4364524 (Del. Ch. July 6, 2023) (McCormick, C.), the Delaware Court of Chancery addressed the circumstances under which the Court will award a shareholder plaintiff attorneys’ fees in disclosure-based deal litigation. In particular, Anderson analyzed the history of disclosure-based deal litigation in Delaware and the Court’s evolving standard for awarding fees where shareholder action has caused a company to issue additiona

52
article thumbnail

PolyMet Accepts Glencore's Offer To Sell Remaining Shares

Benzinga

PolyMet Mining Corp (AMEX: PLM) inked a deal with Glencore PLC (OTC: GLCNF )(OTC: GLNCY ) to sell its remaining 17.8% of shares for $2.11 in cash per share. Glencore presently holds around 82.18% of PloyMet shares. The deal represents a 167% premium over PLM's $0.79 per share price. Full story available on Benzinga.

Equity 52
article thumbnail

How to Value a Footwear Wholesaler

Peak Business Valuation

Demand for the footwear wholesale industry has significantly reduced over the past several years. This downward trend is a result of poor economic conditions as well as intense competition. Although the economy has recovered, industry revenue will not likely return to pre-COVID rates. In addition, competition from online retailers is increasing. If you are looking to buy or sell a footwear wholesaler, it is important to understand its value.

article thumbnail

Why Black Knight Shares Are Surging Today

Benzinga

Intercontinental Exchange Inc (NYSE: ICE ) and Black Knight Inc (NYSE: BKI ) have agreed to sell Black Knight's Optimal Blue business to a subsidiary of Constellation Software Inc (OTC: CNSWF ) for $700 million. In May 2022, ICE announced the acquisition of Black Knight in a cash and stock transaction for $85 per share or a market value of $13.1 billion.

article thumbnail

20 Exit Planning Questions that Every Business Owner Should Ask Themselves

Exit Strategy

Eventually every business owner will hand over the keys, and in my experience, the further that the owners plan ahead the happier they’ll be with their exit. While there are many things to consider when planning an exit, particularly for owner-operators of businesses, here is a list of questions that every business owner should be […] The post 20 Exit Planning Questions that Every Business Owner Should Ask Themselves appeared first on Exit Strategies Group, Inc.

52
article thumbnail

Why Are Novan Shares Nosediving Today?

Benzinga

Novan Inc (NASDAQ: NOVN ) shares are trading lower after Ligand Pharmaceuticals Incorporated (NASDAQ: LGND ) announced that it has offered to acquire the company's assets. The deal value includes $15 million in cash and provides up to $15 million in DIP financing to Novan, including a $3 million bridge loan already funded. Novan announced earlier today that it has filed for Chapter 11 reorganization and its entry into a stalking horse acquisition offer.

Finance 52
article thumbnail

FCF Valuation Monitor – Q2 2023 published

Fox Corporate Finance

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q2 2023”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and. Read more The post FCF Valuation Monitor – Q2 2023 published appeared first on FCF Fox Corporate Finance GmbH.

article thumbnail

Travere Therapeutics Offloads Bile Acid Product Portfolio: Says Divestment Strengthens Financial Foundation

Benzinga

Travere Therapeutics Inc (NASDAQ: TVTX ) has agreed to sell its bile acid product portfolio that, which includes Cholbam (cholic acid) and Chenodal (chenodiol), two medications, to Mirum Pharmaceuticals Inc (NASDAQ: MIRM ). Mirum will purchase Travere's bile acid product portfolio for up to $445 million, consisting of $210 million upfront and $235 million in potential sales- based milestone payments.

52
article thumbnail

Is MENAP’s budding start-up ecosystem ready to blossom?

Mckinsey and Company

Some of the world’s wealthiest venture capital investors call the region home, but it has not been a hot spot for start-ups. Now powerful trends are shifting this dynamic.

article thumbnail

Microsoft, UK's Competition And Markets Authority Seek Extension For $69B Activision Deal

Benzinga

In a bid to overcome opposition to its proposed $69 billion acquisition of video game maker Activision Blizzard Inc (NASDAQ: ATVI ), Microsoft Corp (NASDAQ: MSFT ) and the U.K.'s Competition and Markets Authority (CMA) have jointly sought additional time from London's Competition Appeal Tribunal (CAT). Efforts were made on Monday as lawyers representing Microsoft and the CMA presented their case to Judge Marcus Smith, seeking a delay in a scheduled hearing, according to The Washington Po

article thumbnail

MTN Group CEO Ralph Mupita: Bridging Africa’s connectivity gap

Mckinsey and Company

The head of the continent’s largest mobile operator talks about technology’s role in fostering sustainable growth and how his company’s delayering strategy can help accelerate that transformation.

52
article thumbnail

Buyout groups raise debt against portfolios to return cash as dealmaking slows

Financial Times M&A

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

70
article thumbnail

Delaware Court of Chancery Clarifies Heightened Standard for Recovery of Attorneys’ Fees in Disclosure-Based Deal Litigation

National Law Review M&A

John P. Stigi III Alejandro E.

81